Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedNov 23, 2024
DataAggregated Company Financials
Companies4
  • 7D0.2%
  • 3M10.8%
  • 1Y14.0%
  • YTD12.6%

Over the last 7 days, the Pharma industry has remained flat, although notably Hyphens Pharma International gained 5.4%. The past year has been better, since the industry has gained 14% in that time. Earnings are forecast to grow by 6.7% annually.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 23 Nov 2024S$2.6bS$449.4mS$232.7m9.6x11.2x5.8x
Mon, 21 Oct 2024S$2.6bS$448.3mS$232.7m9.5x11x5.7x
Wed, 18 Sep 2024S$2.5bS$448.2mS$232.7m9.4x10.9x5.6x
Fri, 16 Aug 2024S$2.4bS$438.2mS$233.4m9.2x10.2x5.4x
Sun, 14 Jul 2024S$2.4bS$431.9mS$216.0m9.7x11.1x5.6x
Tue, 11 Jun 2024S$2.3bS$432.0mS$216.0m9.5x10.6x5.3x
Thu, 09 May 2024S$2.3bS$417.3mS$214.6m9.7x10.5x5.4x
Sat, 06 Apr 2024S$2.3bS$417.2mS$214.6m10x10.7x5.5x
Mon, 04 Mar 2024S$2.3bS$417.2mS$214.6m10.1x10.7x5.5x
Wed, 31 Jan 2024S$2.2bS$371.1mS$172.1m12.3x13x6x
Fri, 29 Dec 2023S$2.3bS$370.9mS$172.1m12.7x13.2x6.1x
Sun, 26 Nov 2023S$5.4bS$1.6bS$310.7m12.3x17.4x3.5x
Tue, 24 Oct 2023S$4.9bS$1.5bS$326.5m9.9x15.1x3.2x
Thu, 21 Sep 2023S$5.4bS$1.5bS$327.0m10.2x16.4x3.5x
Sat, 19 Aug 2023S$5.4bS$1.5bS$313.9m10.2x17.1x3.5x
Mon, 17 Jul 2023S$5.8bS$1.5bS$290.4m9.7x19.9x3.7x
Wed, 14 Jun 2023S$6.4bS$1.5bS$290.2m10.7x22x4.1x
Fri, 12 May 2023S$6.4bS$1.6bS$296.6m11x21.6x4x
Sun, 09 Apr 2023S$6.0bS$1.6bS$268.8m11.5x22.5x3.9x
Tue, 07 Mar 2023S$5.6bS$1.4bS$264.0m9.4x21.3x4.1x
Thu, 02 Feb 2023S$5.4bS$1.4bS$265.3m8.7x20.2x3.8x
Sat, 31 Dec 2022S$4.9bS$1.4bS$262.4m8.8x18.9x3.6x
Mon, 28 Nov 2022S$5.1bS$1.3bS$257.8m8.2x19.8x3.8x
Wed, 26 Oct 2022S$4.3bS$1.3bS$245.0m9.9x17.5x3.3x
Fri, 23 Sep 2022S$4.6bS$1.3bS$248.2m10.5x18.6x3.4x
Sun, 21 Aug 2022S$4.8bS$1.4bS$254.7m11.2x18.8x3.5x
Tue, 19 Jul 2022S$4.8bS$1.3bS$228.3m10x21x3.6x
Thu, 16 Jun 2022S$4.9bS$1.3bS$228.6m10.5x21.2x3.6x
Sat, 14 May 2022S$4.7bS$1.3bS$226.8m10.8x20.7x3.6x
Mon, 11 Apr 2022S$5.3bS$1.4bS$236.3m11.5x22.3x3.8x
Wed, 09 Mar 2022S$5.4bS$1.4bS$249.4m12.2x21.5x3.8x
Fri, 04 Feb 2022S$5.4bS$1.3bS$212.5m14.1x25.2x4x
Sun, 02 Jan 2022S$5.8bS$1.3bS$212.7m14.4x27.4x4.4x
Tue, 30 Nov 2021S$5.3bS$1.3bS$211.9m14x25.2x4x
Price to Earnings Ratio

25.2x


Total Market Cap: S$5.3bTotal Earnings: S$211.9mTotal Revenue: S$1.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 17.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Singaporean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.2x which is lower than its 3-year average PE of 17.7x.
  • The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.2% per year over the last three years.
  • Meanwhile revenues for these companies have declined 30% per year.
  • This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare industry?

SG Market0.0067%
Healthcare0.33%
Pharma0.15%
Pharma0.15%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1J5 Hyphens Pharma InternationalS$0.295.4%
+S$4.6m
7.3%PE8.8x
42C iX BiopharmaS$0.0244.3%
+S$883.3k
-46.7%PS3.6x
BFK Pharmesis InternationalS$0.653.2%
+S$634.0k
633.0%PS2.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.